News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LeMaitre Vascular, Inc. Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)



7/28/2017 10:47:07 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

BURLINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2017 results, provided increased guidance, announced a $0.055/share dividend and authorized a $7.5mm share repurchase program.

Q2 2017 Results

  • Record sales of $25.8mm, +15% vs. Q2 2016
  • Record operating income of $5.5mm, +46%
  • Record net income of $4.6mm, +78%
  • Record earnings per diluted share of $0.23, +69%
  • Record EBITDA of $6.4mm, +35%
  • Cash & equivalents up $4.3mm during the quarter to $30.1mm

Q2 2017 sales of $25.8mm increased 15% (+10% organic) vs. Q2 2016. Biologic patches and grafts led growth. Sales in the Americas were up 22% while international sales increased 5%.

Gross margin decreased to 68.0% in Q2 2017 from 68.6% in Q2 2016, primarily due to the addition of recently-acquired products, as well as manufacturing inefficiencies.

Operating expenses in Q2 2017 were $12.0mm, a 3% increase vs. the year-earlier quarter, driven by acquisition-related costs.

George W. LeMaitre, Chairman and CEO said, “We continue to pursue 10% annual reported sales growth and 20% annual operating income growth.”


Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES